Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review.
M Di Nisio, A Squizzato, A W S Rutjes...
https://pubmed.ncbi.nlm.nih.gov/17155963/Actively Recruiting
Led by Diagnostica Stago R&D · Updated on 2025-06-26
1836
Participants Needed
4
Research Sites
43 weeks
Total Duration
This research evaluates the diagnostic performance of a new Clinical Decision Support tool using fresh plasma samples in patients suspected of venous thromboembolism VTE, including pulmonary embolism PE and deep vein thrombosis DVT. It compares results from fresh plasma with those from frozen plasma and the current standard diagnostic strategy. The study includes various patient groups, such as those eligible for D-dimer testing, patients with high clinical probability, patients with conditions affecting D-dimer levels, those with recent thrombotic events, active cancer, or COVID-19. The study uses routine coagulation tests and the new Clinical Decision Support algorithm on both fresh and frozen plasma samples. The algorithm applies manual or machine learning methods to calculate exclusion scores based on D-dimer and fibrin formation assays. Participants receive standard care and diagnosis according to usual practice while their plasma samples are assessed for comparison. Participants will undergo plasma sampling for routine coagulation and Clinical Decision Support testing on fresh and frozen samples. Researchers will measure outcomes including reproducibility, threshold settings, sensitivity, specificity, likelihood ratios, exclusion percentages, and negative predictive values of the Clinical Decision Support tool over periods of 37 to 48 months. The study aims to verify if fresh plasma testing can match frozen plasma performance, potentially impacting diagnostic algorithms for VTE.
CONDITIONS
Exclusion of Venous Thrombo-Embolism With a New Clinical Decision Support
A
AURELIE LAMIELLE
O
OLIVIER MATHIEU
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Diagnostica Stago R&D
Lead Sponsor
Centre Hospitalier de Niort
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Initial testing period
Participants undergo diagnostic testing including routine coagulation tests and clinical decision support assays on fresh and frozen plasma to assess for venous thrombo-embolism.
1 visit (in-person)
Duration - Up to 48 months
Participants are observed over time to evaluate the reproducibility and diagnostic performance of the clinical decision support tool in detecting pulmonary embolism and deep vein thrombosis.
Periodic assessments during follow-up
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
M Di Nisio, A Squizzato, A W S Rutjes...
https://pubmed.ncbi.nlm.nih.gov/17155963/Michał Ząbczyk, Anetta Undas
https://pubmed.ncbi.nlm.nih.gov/29225327/Sam Schulman, Walter Ageno, Stavros V Konstantinides
https://pubmed.ncbi.nlm.nih.gov/28594049/Marc Righini, Grégoire Le Gal, Arnaud Perrier...
https://pubmed.ncbi.nlm.nih.gov/15935031/Menno V Huisman, Frederikus A Klok
https://pubmed.ncbi.nlm.nih.gov/26585807/ISTH Steering Committee for World Thrombosis Day
https://pubmed.ncbi.nlm.nih.gov/25302663/Arne van Belle, Harry R Büller, Menno V Huisman...
https://pubmed.ncbi.nlm.nih.gov/16403929/M Righini
https://pubmed.ncbi.nlm.nih.gov/17635709/Frederick A Anderson, Frederick A Spencer
https://pubmed.ncbi.nlm.nih.gov/12814980/Graham Pawelec, David Goldeck, Evelyna Derhovanessian
https://pubmed.ncbi.nlm.nih.gov/24762450/Diagnostica Stago R&D
Lead Sponsor
Centre Hospitalier de Niort
Collaborating Sponsor